home > ebr > > pharma research meets synthetic biology


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


Industry Events

3rd Biomarkers in Diagnostics & Therapeutics 2014 (BDT2014)

24-25 September 2014, Singapore

The global biomarkers market displays high growth potential in the near future with a projected value of 40.8 billion by 2018.
More info >>

News and Press Releases

INC Research Drives Deeper Site Connections Through Strengthened Study Start-up Effort

Raleigh, N.C., July 16, 2014 - INC Research, a leading, global Phase I to IV clinical research organization (CRO), today announced the promotion of Carol Aliyar to Senior Vice President, Study Start-Up. Ms. Aliyar will be responsible for leading the Companys global site engagement and study start-up efforts, including study start-up operations, site identification, site start-up and activation, ethics and regulatory submissions/approval and patient recruitment. She brings more than two decades of clinical operations experience to her new role, including broad therapeutic expertise and experience in leading large-scale global clinical development programs. As Senior Vice President, Study Start-Up, Ms. Aliyar will focus on fostering strong site relationships to optimize timelines and deliver rapid study start-up for global clinical trials, establishing the foundation for successful collaboration across the duration of a study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement